Spinal muscular atrophies are a group of genetically and clinically heterogeneous neuromuscular disorders characterized by progressive loss of lower motor neurons, muscle weakness, and atrophy. Approximately 95% of spinal muscular atrophy cases are associated with a deletion of exons 7 and 8 in the survival motor neuron 1 (SMN1) gene, resulting in insufficient levels of SMN protein. The remaining 5% of cases involve mutations in approximately 30 different genes, collectively referred to as non–SMN-related spinal muscular atrophies. These variants often present with distinct clinical features beyond typical spinal muscular atrophy symptoms, including arthrogryposis, extraocular movement abnormalities, brainstem signs, or cardiomyopathy. This review aims to provide an updated genetic landscape of non–SMN-linked spinal muscular atrophy phenotypes and propose a diagnostic protocol to assist clinicians in cases where SMN1 gene sequencing yields no conclusive findings.
LefebvreSBürglenLReboulletS, et al.Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155-165. doi: 10.1016/0092-8674(95)90460-3. PMID: 7813012.
3.
FarrarMAKiernanMC. The genetics of spinal muscular atrophy: progress and challenges. Neurotherapeutics. 2015;12(2):290-302. doi: 10.1007/s13311-014-0314-x. PMID: 25413156; PMCID: PMC4404441.
4.
RamserJAhearnMELenskiC, et al.Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy. Am J Hum Genet. 2008;82(1):188-193. doi: 10.1016/j.ajhg.2007.09.009. PMID: 18179898; PMCID: PMC2253959.
5.
DlaminiNJosifovaDJPaineSM, et al.Clinical and neuropathological features of X-linked spinal muscular atrophy (SMAX2) associated with a novel mutation in the UBA1 gene. Neuromuscul Disord. 2013;23:391-398. doi: 10.1016/j.nmd.2013.02.001
6.
BalakCDHunterJMAhearnMEWileyDD'ursoGBaumbach-ReardonL. Functional characterizations of rare UBA1 variants in X-linked spinal muscular atrophy. F1000Res. 2017;6:1636. doi: 10.12688/f1000research.11878.1
7.
JedrzejowskaMJakubowska-PietkiewiczEKostera-PruszczykA. X-linked spinal muscular atrophy (SMAX2) caused by de novo c.1731C>T substitution in the UBA1 gene. Neuromuscul Disord. 2015;25:661-666. doi: 10.1016/j.nmd.2015.05.00
8.
WanJYourshawMMamsaH, et al.Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nat Genet. 2012;44(6):704-708. doi: 10.1038/ng.2254. PMID: 22544365; PMCID: PMC3366034.
9.
PapadopoulouLCSueCMDavidsonMM, et al.Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet. 1999;23:333-337.
10.
GlerumDMShtankoATzagoloffA. SCO1 And SCO2 act as high copy suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae. J Biol Chem. 1996;271:20531-20535.
11.
SalviatiLSacconiSRasalanMM, et al.Cytochrome c oxidase deficiency due to a novel SCO2 mutation mimics Werdnig-Hoffmann disease. Arch Neurol. 2002;59(5):862-865. doi:10.1001/archneur.59.5.862
12.
HuTChitnisNMonosDDinhA. Next-generation sequencing technologies: an overview. Hum Immunol. 2021;82(11):801-811. doi: 10.1016/j.humimm.2021.02.012. Epub 2021 Mar 19. PMID: 33745759.
13.
NishimuraALMitne-NetoMSilvaHC, et al.A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004;75:822-831.
14.
MoherDLiberatiATetzlaffJAltmanDG. The PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097. 10.1371/journal.pmed.1000097
15.
SheaBJReevesBCWellsGA, et al.AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. Br Med J.2017;358:j4008. 10.1136/bmj.j4008
16.
ChenYZBennettCLHuynhHM, et al.DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet. 2004;74(6):1128-1135. doi: 10.1086/421054. Epub 2004 Apr 21. PMID: 15106121; PMCID: PMC1182077.
17.
MaystadtIRezsohazyRBarkatsM, et al.The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am J Hum Genet. 2007;81:67-76.
18.
La SpadaARWilsonEMLubahnDBHardingAEFischbeckKH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77-79.
19.
Rudnik-SchonebornSBotzenhartEEggermannT, et al.Mutations of the LMNA gene can mimic autosomal dominant proximal spinal muscular atrophy. Neurogenetics. 2007;8:137-142.
20.
RenbaumPKellermanEJaronR, et al.Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene. Am J Hum Genet. 2009;85(2):281-289. doi: 10.1016/j.ajhg.2009.07.006. Epub 2009 Jul 30. PMID: 19646678; PMCID: PMC2725266.
21.
VerverisADajaniRKoutsouP, et al.Distal hereditary motor neuronopathy of the Jerash type is caused by a novel SIGMAR1 c.500A>T missense mutation. J Med Genet. 2020;57(3):178-186. doi: 10.1136/jmedgenet-2019-106108. Epub 2019 Sep 11. PMID: 31511340; PMCID: PMC7042970.
